Cognition Therapeutics Inc (CGTX)
0.4612
-0.05
(-9.85%)
USD |
NASDAQ |
Nov 15, 16:00
0.4613
0.00 (0.00%)
After-Hours: 20:00
Cognition Therapeutics Enterprise Value: -9.839M for Nov. 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 15, 2024 | -9.839M |
| November 14, 2024 | -7.816M |
| November 13, 2024 | -6.793M |
| November 12, 2024 | -4.332M |
| November 11, 2024 | -7.997M |
| November 08, 2024 | -8.081M |
| November 07, 2024 | -7.471M |
| November 06, 2024 | -8.290M |
| November 05, 2024 | -8.755M |
| November 04, 2024 | -9.309M |
| November 01, 2024 | -9.449M |
| October 31, 2024 | -9.401M |
| October 30, 2024 | -7.037M |
| October 29, 2024 | -5.472M |
| October 28, 2024 | -6.592M |
| October 25, 2024 | -5.677M |
| October 24, 2024 | -4.674M |
| October 23, 2024 | -4.268M |
| October 22, 2024 | -8.984M |
| October 21, 2024 | -9.417M |
| October 18, 2024 | -8.506M |
| October 17, 2024 | -10.46M |
| October 16, 2024 | -10.38M |
| October 15, 2024 | -11.45M |
| October 14, 2024 | -11.24M |
| Date | Value |
|---|---|
| October 11, 2024 | -12.28M |
| October 10, 2024 | -11.93M |
| October 09, 2024 | -12.29M |
| October 08, 2024 | -12.29M |
| October 07, 2024 | -11.89M |
| October 04, 2024 | -10.89M |
| October 03, 2024 | -10.89M |
| October 02, 2024 | -10.25M |
| October 01, 2024 | -10.68M |
| September 30, 2024 | -9.542M |
| September 27, 2024 | -11.46M |
| September 26, 2024 | -11.89M |
| September 25, 2024 | -11.69M |
| September 24, 2024 | -8.755M |
| September 23, 2024 | -7.459M |
| September 20, 2024 | -5.087M |
| September 19, 2024 | -3.891M |
| September 18, 2024 | -4.304M |
| September 17, 2024 | -4.738M |
| September 16, 2024 | -4.469M |
| September 13, 2024 | -4.264M |
| September 12, 2024 | -4.124M |
| September 11, 2024 | -3.959M |
| September 10, 2024 | -3.967M |
| September 09, 2024 | -4.088M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-18.56M
Minimum
Nov 10 2022
269.09M
Maximum
Nov 09 2021
31.03M
Average
14.41M
Median
Enterprise Value Benchmarks
| NeuroBo Pharmaceuticals Inc | -2.542M |
| Dermata Therapeutics Inc | -3.473M |
| ZyVersa Therapeutics Inc | 0.9921M |
| NovaBay Pharmaceuticals Inc | 2.764M |
| Palatin Technologies Inc | 8.735M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.041M |
| Total Expenses (Quarterly) | 7.367M |
| EPS Diluted (Quarterly) | -0.18 |
| Earnings Yield | -203.8% |